Answers are grounded in this paper and cite their sources.
Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study. January 09, 2017 Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study. November 21, 2016 ARTICLE CITATION DOI: 10.1200/JCO.2016.71.0616 Journal of Clinical Oncology - published online before print January 23, 2017 PMID: 28113009 DNA Methylation–Based Biomarkers Leandro CerchiettixLeandro CerchiettiSearch for articles by this author and Ari MelnickxAri MelnickSearch for articles by this author Show More Leandro Cerchietti and Ari Melnick, Weill Cornell Medicine, New York, NY https://doi.org/10.1200/JCO.2016.71.0616 First Page Full Text PDF Figures and Tables © 2017 by American Society of Clinical Oncology Companion CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
No takes yet. Share an insight, caveat, or question.
Cerchietti et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: